alpha-aminopyridine has been researched along with Cystitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, H; Li, N; Liu, Y; Wang, P; Zhang, P | 1 |
| Hayashi, R; Hirano, N; Momen, S; Nagahara, T; Takahashi, E; Yokokawa, H; Yoshikawa, S | 1 |
2 other study(ies) available for alpha-aminopyridine and Cystitis
| Article | Year |
|---|---|
The phosphodiesterase type 4 inhibitor roflumilast suppresses inflammation to improve diabetic bladder dysfunction rats.
Topics: Aminopyridines; Animals; Benzamides; Cyclopropanes; Cystitis; Diabetes Complications; Diabetes Mellitus, Experimental; Female; Inflammation; Interleukin-1beta; Interleukin-6; NF-kappa B; Phosphodiesterase 4 Inhibitors; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tumor Necrosis Factor-alpha; Urodynamics | 2019 |
Discovery of potent transient receptor potential vanilloid 1 antagonists: design and synthesis of phenoxyacetamide derivatives.
Topics: Acetamides; Aminopyridines; Animals; Capsaicin; Cystitis; Drug Design; Drug Evaluation, Preclinical; Humans; Protein Binding; Rats; Structure-Activity Relationship; TRPV Cation Channels | 2013 |